Nautilus Biotechnology, Inc.(NAUT)— Stock Profile, AI Score & Financials

Technology · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-03-31.

Nautilus Biotechnology, Inc. (NAUT) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. NAUT is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Nautilus Biotechnology, Inc. reports net income of $-14.7M, free cash flow of $-13.6M. Top institutional holders of NAUT by reported 13-F value include PERCEPTIVE ADVISORS, a16z Capital Management, L.L.C., Cercano Management, based on the most recent SEC filings. NAUT trades on the Nasdaq exchange and files with the SEC under CIK 1808805. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NAUT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nautilus Biotechnology, Inc. directly from SEC EDGAR.